INKT
MiNK Therapeutics, Inc.NASDAQHealthcare$10.69+7.02%ClosedMarket Cap: $50.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.00
P/S
0.00
EV/EBITDA
0.00
DCF Value
$2,369.61
FCF Yield
-11033.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
82614.8%
ROA
-87.7%
ROIC
0.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | Infinity% | $9.2M | $-12.48B | $-0.52 | — |
| FY 2025 | $0.00 | NaN% | $0.00 | $-12.49B | $-2.93 | — |
| Q3 2025 | $0.00 | -Infinity% | $-3.0M | $-2.9M | $-0.65 | — |
| Q2 2025 | $0.00 | -Infinity% | $-3.7M | $-4.2M | $-1.06 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.5M | $-2.8M | $-0.70 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.2M | $-2.5M | $-0.65 | — |
| FY 2024 | $0.00 | -Infinity% | $-10.7M | $-10.8M | $-2.80 | — |
| Q3 2024 | $0.00 | -Infinity% | $-1.7M | $-1.8M | $-0.46 | — |
| Q2 2024 | $0.00 | -Infinity% | $-2.9M | $-2.7M | $-0.73 | — |
| Q1 2024 | $0.00 | -Infinity% | $-3.8M | $-3.8M | $-1.10 | — |
| Q4 2023 | $0.00 | -Infinity% | $-5.5M | $-5.5M | $-1.58 | — |
| FY 2023 | $0.00 | -Infinity% | $-22.9M | $-22.5M | $-6.54 | — |